key: cord-0727888-13f4kvnx
authors: Strasburger, Janette F.; Wacker-Gussmann, Annette
title: Congenital Heart Block in Subsequent Pregnancies of SSA/Ro-Positive Mothers: Cutting Recurrence in Half
date: 2020-07-21
journal: J Am Coll Cardiol
DOI: 10.1016/j.jacc.2020.05.052
sha: 09d7243536fb2aca47ccb06baba4f6ca7f003d21
doc_id: 727888
cord_uid: 13f4kvnx

[Figure: see text]

T he study reported by Izmirly et al. (1) in this issue of the Journal is a very important multicenter, single-arm, 2-stage clinical trial evaluating an orally administered Toll-like receptor signaling antagonist, hydroxychloroquine (HCQ), in recurrent maternal Sjögren's antibody (SSA/Ro)mediated congenital heart block. As the authors stated, congenital heart block (CHB) has significant morbidity and mortality (17.5%) both before and after birth (1) . A recent Italian Registry of isoimmune CHB in pregnancy reported a live birth rate of about 80%, with nearly two-thirds of the children requiring implantation of a pacemaker after birth (2) . Attempts to reverse second-degree AV block in utero with dexamethasone or intravenous gamma-globulin have been successful in only about 25% of cases, and even when improvement occurs, regression back to CHB still occurs in about one-half of these cases in infancy and even up to age 10 years (3). Although we know HCQ's effects on the QTc of the pregnant patient, what is not known is HCQ's impact on the QTc of the fetus before or with CHB. During sinus rhythm, 2% of normal fetuses will have QTc values of 500 ms (9) . In CHB, many fetuses will demonstrate excessive QTc prolongation, sometimes in the range of 690 ms, with T-wave alternans (10, 11) .

QTc is a function of heart rate, and, thus, with lower ventricular rates and occasional bundle branch block, an increase in QTc can be expected (10, 12 

Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/Ropositive mothers

First report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)

Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/ Ro-SSB/La antibodies

Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela

The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants

Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus

Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)

Considerations for drug interactions on QTc in exploratory COVID-19 (coronavirus disease 2019) treatment

Fetal magnetocardiogram waveform characteristics

Electrophysiological characteristics of fetal atrioventricular block

Complex and novel arrhythmias precede stillbirth in fetuses with de novo long QT syndrome

Fetal cardiac repolarization abnormalities